Long-term COVID and Rehabilitation

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2028

Conditions
Long-COVID
Interventions
DIETARY_SUPPLEMENT

Mitoquinone

Mito-Q is a supplement that targets mitochondrial function. Linking a triphenyl-phosphonium cation to coenzyme-Q, to produce Mito-Q, results in a lipophilic compound, which, due to the large mitochondrial membrane potential, selectively accumulates within mitochondria. This targeted antioxidant approach results in 50- to 100-fold more Mito-Q accumulation compared to non-targeted antioxidant delivery.

DIETARY_SUPPLEMENT

Placebo

A placebo will be used in combination with exercise rehabilitation allowing for a double blinded placebo controlled design.

Trial Locations (1)

84148-0001

RECRUITING

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City

All Listed Sponsors
lead

VA Office of Research and Development

FED